Published in J Econ Entomol on April 01, 2016
Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet (2001) 3.27
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac Radiol (2010) 2.15
Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res (1991) 1.88
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des (2008) 1.82
Simple technique for closure of skin lacerations under tension. Ann R Coll Surg Engl (2011) 1.61
Cystic hygroma and congenital diaphragmatic hernia: early prenatal sonographic evaluation of Fryns' syndrome. Prenat Diagn (1992) 1.45
Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma. Ann Surg Oncol (1995) 1.44
Risk of miscarriage and a common variant of the estrogen receptor gene. Am J Epidemiol (1993) 1.39
Recognition of electrocardiographic electrode misplacements involving the ground (right leg) electrode. Am J Cardiol (1993) 1.37
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res (1997) 1.36
Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J Med Genet (2003) 1.31
Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet (2002) 1.23
Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med (2010) 1.21
Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood (1998) 1.18
Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem (1996) 1.14
T-cell-independent elimination of Borrelia turicatae. Infect Immun (1984) 1.08
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
In vivo evidence that an intact lytic complement pathway is not essential for successful removal of circulating Borrelia turicatae from mouse blood. Infect Immun (1981) 1.07
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
An additional 136 SSLP markers typed for the AXB and BXA recombinant inbred mouse strains. Mamm Genome (1997) 1.04
Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res (1998) 1.03
Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Ther (2000) 1.02
Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp Lung Res (2001) 1.02
Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis (1995) 1.02
Heavy metal contamination and distribution in the urban environment of Guangzhou, SE China. Environ Geochem Health (2006) 1.01
The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci U S A (1994) 1.00
Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res (2001) 1.00
Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res (1990) 1.00
Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect (1992) 0.99
At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice. Genomics (1998) 0.98
The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene (2006) 0.98
Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from Erythroxylum pervillei. J Nat Prod (2001) 0.95
A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy. Cancer Gene Ther (2009) 0.95
Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis (1993) 0.94
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene (2006) 0.91
A strategy for resection of Wilms' tumor with vena cava or atrial extension. J Pediatr Surg (1992) 0.91
Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene (1996) 0.90
5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model. Carcinogenesis (1999) 0.90
Amitriptyline in human breast milk and the nursing infant's serum. Am J Psychiatry (1980) 0.89
Single nucleotide polymorphism (SNP) analysis of mouse quantitative trait loci for identification of candidate genes. J Med Genet (2004) 0.89
Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines. Exp Lung Res (2001) 0.88
K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis (1995) 0.88
Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res (2000) 0.88
The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg (1991) 0.87
Meeting the information needs of clinicians for the practice of evidence-based healthcare. Health Libr Rev (1999) 0.87
Entropy and distance of random graphs with application to structural pattern recognition. IEEE Trans Pattern Anal Mach Intell (1985) 0.87
Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia. Am J Med Sci (1986) 0.86
Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res (1994) 0.85
Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene (1995) 0.85
Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res (2000) 0.85
The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog (1994) 0.85
Quality of life among advanced breast cancer patients with and without distant metastasis. Eur J Cancer Care (Engl) (2012) 0.84
Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Mol Carcinog (1999) 0.84
Moxalactam and piperacillin: a study of in vitro characteristics and pharmacokinetics in cancer patients. Infection (1985) 0.84
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Carcinogenesis (1998) 0.84
Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl (1997) 0.83
Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors. Carcinogenesis (1998) 0.83
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell Growth Differ (2000) 0.83
Chemopreventive efficacy of promising farnesyltransferase inhibitors. Exp Lung Res (2000) 0.83
Excretion of chloroquine, dapsone and pyrimethamine in human milk. Br J Clin Pharmacol (1986) 0.83
Cyclin D1 as a proliferative marker regulating retinoblastoma phosphorylation in mouse lung epithelial cells. Cancer Lett (2001) 0.83
Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. Oncogene (2009) 0.83
Prevention of lung cancer progression by bexarotene in mouse models. Oncogene (2006) 0.81
Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene. Mamm Genome (1997) 0.81
Psychogenic seizures in old age: a case report. Epilepsia (1994) 0.81
Molecular evidence of Babesia caballi (Nuttall and Strickland, 1910) parasite transmission from experimentally-infected SCID mice to the ixodid tick, Haemaphysalis longicornis (Neuman, 1901). Vet Parasitol (2001) 0.81
Drug delivery by genetically engineered cell implants. Ann N Y Acad Sci (1991) 0.81
Effects of castration and chronic morphine administration on liver alcohol dehydrogenase and the metabolism of ethanol in the male Sprague-Dawley rat. J Pharmacol Exp Ther (1980) 0.80
ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice. Cancer Res (1993) 0.80
Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Carcinogenesis (1994) 0.80
Successful closure of intestinal fistulae in an infant using the somatostatin analogue SMS 201-995. J Pediatr Surg (1991) 0.79
Anthropometry of Taiwanese women. Appl Ergon (1994) 0.79
Single nucleotide polymorphism (SNP) analysis of mouse pulmonary adenoma susceptibility loci 1-4 for identification of candidate genes. J Med Genet (2003) 0.79
Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor. Oncogene (2001) 0.78
Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. J Cell Biochem Suppl (1997) 0.78
Radiographic preoperative templating of extra-offset cemented THA implants: how reliable is it and how does it affect survival? Orthop Traumatol Surg Res (2010) 0.78
Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice. Gene (1997) 0.78
Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis. J Cell Biochem Suppl (1997) 0.78
Protooncogene activation in spontaneously occurring and chemically induced rodent and human lung tumors. Prog Clin Biol Res (1992) 0.78
Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas. Mol Carcinog (2001) 0.78
Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia. Mol Carcinog (1998) 0.78
Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes. Carcinogenesis (1997) 0.78
Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats. Br J Pharmacol (2007) 0.78
Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors. Exp Lung Res (1998) 0.78
Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis (2000) 0.78
Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Ann Allergy Asthma Immunol (2001) 0.78
Detection of genomic alterations in human cervical cancer by two-dimensional gel electrophoresis. J Cell Biochem Suppl (1996) 0.77
Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Mol Carcinog (1996) 0.77
Prospects for prenatal gene therapy in disorders causing mental retardation. Ment Retard Dev Disabil Res Rev (2001) 0.77
Mission impossible? The definition and functions of the medical director. Health Manpow Manage (1997) 0.77
Brief communication, P53 accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors. Toxicol Pathol (1996) 0.76
Small molecule antagonists of the bradykinin B1 receptor. Immunopharmacology (1999) 0.76
Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Cancer Res (1991) 0.76
Characteristic features of the adenomatoid odontogenic tumour on cone beam CT. Dentomaxillofac Radiol (2014) 0.75
B region variant of the estrogen receptor gene. Nucleic Acids Res (1992) 0.75
Detection of differentially expressed genes in mouse lung adenocarcinomas. Exp Lung Res (2001) 0.75
Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group. Ann Allergy Asthma Immunol (2000) 0.75
[Arthropod diversity in leafy vegetable field and sampling technology]. Ying Yong Sheng Tai Xue Bao (2000) 0.75